Infobird Co., Ltd Provides Digital and Intelligent Customer Engagement Solution to Enhance Patient Vaccination Notification Services for a Top-10 Global Pharmaceutical Company’s Subsidiary
BEIJING, June 29, 2022 /PRNewswire/ -- Infobird Co., Ltd (NASDAQ: IFBD) ("Infobird" or the "Company"), a leading provider of AI-powered customer engagement solutions in China, today announced that it has started to provide services to a leading global pharmaceutical and vaccine manufacturer's subsidiary with operations in China. Under this cooperation, Infobird will leverage its AI Chatbots and experience in...
Akeso’s Cadonilimab (PD-1/CTLA-4), the First Dual Immune Checkpoint Inhibitor to Treat Cancer, Approved for Marketing in China
Globally first dual immune checkpoint inhibitor bi-specific antibody approved for marketing China's first immunotherapy bi-specific antibody approved for marketing A phase III trial of Cadonilimab combined with platinum-based chemotherapy +/- bevacizumab for the first-line treatment of recurrent/metastatic cervical cancer has completed patients enrollment, a phase III trial of Cadonilimab plus...
BioLineRx Enters Co-Development Agreement with GenFleet to Further Develop Motixafortide in Pancreatic Ductal Adenocarcinoma (PDAC), Advised by MSQ Ventures
NEW YORK, June 29, 2022 /PRNewswire/ -- M.S.Q. Ventures ("MSQ") is pleased to announce that its client, BioLineRx Ltd. ("BioLineRx") (NASDAQ/TASE: BLRX), has successfully entered into a co-development agreement with GenFleet Therapeutics, Inc., an immuno-oncology focused biopharmaceutical company based in Shanghai, China, for the development of Motixafortide in pancreatic ductal adenocarcinoma ("PDAC"). Under...
Positive data from the clinical phase I MAD study with AlzeCure’s Alzheimer’s project NeuroRestore ACD856
STOCKHOLM, June 29, 2022 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced that the company has completed the clinical phase I study (multiple ascending dose, MAD) with repeated dosing of...
Seegene to pave way for PCR testing at local clinics with EU-approved multiplex test and fully automated PCR solution
SEOUL, South Korea, June 29, 2022 /PRNewswire/ -- Seegene Inc. (KQ096530), South Korea's leading molecular diagnostics (MDx) company, has obtained EU approval for its Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay that is compatible with the company's fully automated 'AIOS' (All-in-One System). This is expected to help small hospitals, local clinics, and public health centers effectively...
DBN Group Jointly Tackle Down Pressing Agricultural Problems with Top-notch Scientist and Award Winners
Zhongguancun Global Agricultural Science and Technology Innovation Forum Held to Strengthen Tech-driven Force BEIJING, June 29, 2022 /PRNewswire/ -- Beijing Dabeinong Science and Technology Group Co., Ltd., an agricultural high-tech enterprise, lately hosts the Zhongguancun Global Agricultural Science and Technology Innovation Forum ("the Forum") through Global Agricultural Technology Innovation Platform (GAIN) to explore the latest research finding from the...
Mentice receives an initial order of USD 1.93million for simulation solutions and development services from Medtronic
GOTHENBURG, Sweden, June 29, 2022 /PRNewswire/ -- Mentice, Gothenburg (STO: MNTC), a world leader in simulation solutions for image-guided interventional therapies, announced today that Medtronic, Dublin (NYSE: MDT), a global healthcare technology leader, has signed an agreement to acquire Mentice VIST® simulation solutions and development services, in an initial order of USD 1.93 million. The initial order includes the development...
Supporting Communities and Sharing Happiness, 28 Liberty Successfully Hosts Multiple Community Events at New York’s Fosun Plaza
NEW YORK, June 29, 2022 /PRNewswire/ -- As the summer arrives, New Yorkers have been enjoying their favorite season in the year. Starting from early June, in just 3 weeks, Fosun's 28 Liberty has successfully hosted multiple community events at Fosun Plaza with thousands of participants, in support of local community and to promote arts and culture access to...
Sequential awarded prestigious Innovate UK SMART Grant to propel understanding of skin microbiome forward
LONDON and NEW YORK and SINGAPORE, June 29, 2022 /PRNewswire/ -- Sequential Skin Ltd, a leading skin genomics start-up, has been awarded an Innovate UK SMART Grant to fund a project on advancing current understanding of the skin microbiome in healthy and diseased skin - using their novel testing kits. Sequential awarded prestigious Innovate UK SMART Grant to...
Innovent Announces Phase 1b Study Results of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes Published in Nature Communications
SAN FRANCISCO and SUZHOU, China, June 29, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, announces that phase 1b study results of mazdutide (IBI362), a glucagon-like peptide-1 (GLP-1) and glucagon receptor dual agonist, in Chinese patients...
